Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
These findings emphasise the significant impact of OLZ on the GM and its contribution to MS. These findings suggest that interventions targeting the GM, such as probiotics, could mitigate the metabolic side effects of OLZ. Future research should focus on developing integrative treatment approaches that consider the health of the gut microbiome in managing antipsychotic-induced adverse effects.
Authors
- Jesil Mathew Aranjani (ORCID: https://orcid.org/0000-0002-7666-3252)
- Mohandas Rao KG (ORCID: https://orcid.org/0000-0001-5832-0718)
- Shalini Adiga (ORCID: https://orcid.org/0000-0002-3369-194X)
- Kiran Chawla (ORCID: https://orcid.org/0000-0002-4010-4088)
- Veena Nayak (ORCID: https://orcid.org/0000-0002-9372-2680)
- Mushraf Syed (ORCID: https://orcid.org/0000-0001-9168-5735)
- Vasudha Devi (ORCID: https://orcid.org/0000-0003-0292-6352)
- Fayaz SM (ORCID: https://orcid.org/0000-0002-1212-7952)
- Padmaja A. Shenoy (ORCID: https://orcid.org/0000-0001-6781-5579)
Institutions
- Manipal Academy of Higher Education (IN)
- Kasturba Medical College, Manipal (IN)
Publication Details
- Journal
- Gut Pathogens
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1186/s13099-024-00664-2
- Citations
- 3
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.70